Key result
Right mini-thoracotomy for myxomatous mitral valve repair yielded similar freedom from re-operation (98.2% vs 98.2%, P=0.800) and cross-clamp times compared to median sternotomy.
Why the study?
Right mini-thoracotomy for isolated mitral valve repair offers clinical advantages over median sternotomy, but has consistently been associated with longer cross-clamp times and higher operative costs.
Does a right mini-thoracotomy approach improve postoperative outcomes and reduce costs compared to median sternotomy in patients undergoing isolated myxomatous mitral valve repair?
Cohort (n=287)
No
Does a right mini-thoracotomy approach improve postoperative outcomes and reduce costs compared to median sternotomy in patients undergoing isolated myxomatous mitral valve repair?
Absolute Event Rate: 98.2% vs 98.2%
p-value: p=0.800
Right mini-thoracotomy for isolated myxomatous mitral valve repair offers reduced postoperative morbidity, shorter hospital stays, and lower costs compared to median sternotomy, without increasing cross-clamp time or compromising intermediate outcomes.
May support mini-thoracotomy as alternative for myxomatous mitral repair; leaves open randomized trials to confirm outcomes.
BACKGROUND: A right mini-thoracotomy (RT) versus median sternotomy (MS) approach for isolated mitral valve (MV) repair has been associated with less postoperative morbidity, shorter hospital stay, and faster functional recovery, but with consistently longer cross-clamp time and higher operative costs. METHODS: We assessed the impact of a modified operative technique on outcomes in 158 RT versus 129 MS patients treated with myxomatous MV repair from 2016 through 2021. Propensity matching based upon the Society of Thoracic Surgeons Risk Score was used to compare 108 patients in each cohort. RESULTS: Propensity-matched RT patients had reductions in total ventilation time (P=0.025), postoperative atrial fibrillation (P=0.019), and hospital length of stay (P<0.001). RT and MS patients had similar cross-clamp times (66.4±13.7 vs 64.8±16.0 minutes, P=0.414), with less overall leaflet resection (32.4% vs 57.4%, P<0.001) and fewer Gore-Tex NeoChords implanted per patient (1.7±0.7 vs 2.1±1.0, P=0.028) in the RT group. The two cohorts did not differ with respect to 30-day major surgical complications. No patient died and there was no difference between the two groups with respect to freedom from re-operation (98.2% vs 98.2%, P=0.800) at a mean follow-up of 21.4±18.5 months. Direct total hospital costs were lower for the RT group (P=0.018), with reductions in postoperative charges offsetting increased operating room costs. CONCLUSIONS: In this single-center study, the RT compared to the MS approach for myxomatous MV repair resulted in less postoperative morbidity and shorter hospital length of stay, with similar cross-clamp time, reduced total hospital costs, and comparable intermediate outcomes.
No takes yet. Share an insight, caveat, or question.
Hashim et al. (2022) conducted a cohort in Myxomatous mitral valve disease (n=287). Right mini-thoracotomy vs. Median sternotomy was evaluated on Freedom from re-operation (p=0.800). Right mini-thoracotomy for myxomatous mitral valve repair yielded similar freedom from re-operation (98.2% vs 98.2%, P=0.800) and cross-clamp times compared to median sternotomy.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: